- Client: James Richardson (Springfield, IL)
Category: Pharmaceutical Litigation
Start Date: March 10, 2022
End Date: November 15, 2023
Tag: Drug Injury, Mass Tort, Settlement
Budget: $750,000 USD
The Case
James, a 38-year-old sickle cell patient, developed acute liver failure after taking Oxbryta for 18 months. Despite FDA warnings, the manufacturer failed to adequately warn about hepatotoxicity risks.
Key Challenges:
Proving causation between Oxbryta and liver damage
Overcoming the drugmaker’s “benefit outweighs risk” defense
Demonstrating permanent disability from liver transplant
Turning Points:
Uncovered internal memos showing company knew about liver risks
Partnered with hepatology expert who testified about drug-induced injury
Demonstrated James' medical bills exceeded $2.3 million
Outcome:
$4.2 million settlement covering:
✓ Lifelong medical care
✓ Lost earning capacity
✓ Pain and suffering
Contact
Contact Us
let's talk!
Call us today, leave a message or email.
address
Los Angeles, California, USA.
let's connect
CollectiveClaim provides dedicated legal representation for victims.
Navigation
Sign Up for Our Newsletter
© 2025 CollectiveClaim | All Rights Reserved.